Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SR1375 in hospitalized CAP
NCT06577558Phase 2Recruiting
- Sponsor
- Shanghai SIMRD Biotechnology Co., Ltd.
- Start
- Sep 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SR1375 in community acquired pneumonia (CAP), sponsored by Shanghai SIMRD Biotechnology Co., Ltd.. Started Sep 2024; status: recruiting.
02
Drugs
SR1375
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT06577558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06577558.